Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

2.77
Delayed Data
As of 3:59pm ET
 -0.05 / -1.77%
Today’s Change
2.53
Today|||52-Week Range
14.22
-79.59%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close2.82
Today’s open2.81
Day’s range2.73 - 2.84
Volume796,239
Average volume (3 months)1,925,763
Market cap$246.3M
Dividend yield--
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)-135.21%
Earnings growth (this year)+2.27%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-29.86%
P/E ratioNM
Price/Sales4.46
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RXDXIgnyta Inc-0.03-0.46%
SELBSelecta Biosciences ...+1.96+13.06%
PFNXPfenex Inc-0.32-3.52%
PTGXProtagonist Therapeu...+1.15+6.76%
Data as of 4:01pm ET, 09/26/2016

Financials

Next reporting dateOctober 21, 2016
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$60.0M
Annual profit (last year)-$144.8M
Net profit margin-241.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

Search for Jobs